Further Studies on a Mixture of Fatty Acids from Sugar Cane (Saccharum officinarum) Wax Oil in Animal Models of Hypersensitivity

Abstract

A mixture of fatty acids obtained from sugar cane wax oil, the main components of which are palmitic, oleic, linoleic and linolenic acids, was evaluated topically in two experimental models of hypersensitivity: the ear swelling response to ovalbumin in sensitized mice (ED₅₀ edema: 0.63 ± 0.06 mg/ear, ED₅₀ myeloperoxidase: 0.56 ± 0.04 mg/ear, ED₅₀ degranulated cells: 0.70 ± 0,08 mg/ear) and oxazolone-induced contact hypersensitivity in mice (ED₅₀ edema: 1.63 ± 0.26 mg/ear, ED₅₀ myeloperoxidase: 1.50 ± 0.28 mg/ear, ED₅₀ degranulated cells: 1.69 ± 0.08 mg/ear). Also, the effect of this mixture was studied on the chemotaxis induced by fmlp (ED₅₀ : 25 ± 3 μg/mL). The mixture showed anti-inflammatory activity in both in vivo models of allergy and in the chemotaxis test. Therefore, these results provide evidence about the potential usefulness of the mixture of fatty acids from sugar cane wax oil in cutaneous inflammatory and allergic disorders.

Fatty acids - allergy - inflammation - chemotaxis - sugar cane wax oil - Saccharum officinarum L. - Poaceae

References

• 1 Ledon N, Casaco A, Rodriguez V, Cruz J, Gonzalez R, Tolon Z, Cano M, Rojas E. Anti-inflammatory and analgesic effects of a mixture of fatty acids isolated and purified from sugar cane wax oil.  Planta Medica. 2003;  69 367-9
• 2 Meydani S N. Effect of n-3 polyunsaturated fatty acids on cytokine production and their biologic function.  Nutrition. 1998;  12 S8-S14
• 3 Wallace F A, Noely S J, Miles E A, Calder P C. Dietary fats affect macrophage-mediated cytotoxicity towards tumour cells.  Immunol Cell Biol. 2000;  78 40-8
• 4 Okuyama H, Kobayashi T, Watanabe S. Dietary fatty acids-the n-6/n-3 balance and chronic elderly diseases. Excess linoleic acid and relative n-3 deficiency syndrome seen in Japan.  Prog Lipid Res. 1997;  35 409-57
• 5 Pomunski J and Kopacs B. Developments in extraction of sugar cane wax.  Brit Chem Eng. 1960;  12 850-3
• 6 Hessel E M, Van Oosterhout A, Hofstra C L. et al . Bronchoconstriction and airway hyperresponsiveness after ovalbumin inhalation in sensitized mice.  Eur J Pharmacol Environ Toxicol Pharmacol. 1995;  Section 293 401-12
• 7 Glaser K B, Sung M LA, Hartman D A, Lock Y W, Bauer J, Walter T, Carlson R P. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2.  Skin Pharmacol. 1995;  8 300-8
• 8 Romay C, Ledon N, Gonzalez R. Further studies on anti-inflammatory activity of phycocyanin in some animals models of inflammation.  Inflamm Res. 1998;  47 334-8
• 9 Casacó A, Ledón N, González A, Merino N, Pérez R. Topical anti-inflammatory activity of human recombinant epidermal growth factor.  Skin Pharmacol Appl Skin Physiol. 1999;  12 79-84
• 10 Spellberg B, Edwards J E. Type1/Type2 immunity in infectious diseases.  CID. 2001;  32 76-102
• 11 Grimble R F, Tappia P S. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids.  Z Ernaehrungswiss. 1998;  37 ( 1) 57-68
• 12 Stulnig T M, Berger M, Roden M, Stingl H, Raederstorff D, Waldhausl W. Elevated serum free fatty acid concentrations inhibit T lymphocyte signaling.  FASEB. 2000;  14 939-47
• 13 Gamberucci A, Fulcery R, Benedetty A. Inhibition of store-dependent capacitative Ca²⁺ influx by unsaturated fatty acids.  Cell Calcium. 1997;  21 375-85
• 14 Pompeia C, Lopes R L, Miyasaka C K, Procopio J, Sannomiya P Curi R. Effect of fatty acids on leukocyte function.  Braz J Med Biol Res. 2000;  33 1255-68